In today’s briefing:
- Eisai Co (4523 JP): Positive Trial Result For Alzheimer’s Disease Drug- A Step Closer to Approval
- Appier (4180) | Five Reasons to Remain Bullish
- Lawson Confirms Seijo Ishii IPO
- Criteria for TOPIX Components and Prime Market Listing Criteria Should Be Discussed Separately
- Continuing Deflationary Cycle Will Not Raise Younger Generation’s Desire to Marry and Have Children
Eisai Co (4523 JP): Positive Trial Result For Alzheimer’s Disease Drug- A Step Closer to Approval
- Eisai Co Ltd (4523 JP) has announced positive clinical trial results for its Alzheimer’s disease (AD) drug candidate, lecanemab. Lecanemab succeeded in slowing cognitive decline by 27%.
- Importantly, the study shows that removal of aggregated amyloid beta in the brain is associated with a slowing of disease in patients, thereby opening innovation pathway for new treatment options.
- Eisai aims to file for traditional approval in the U.S. and to submit marketing authorization applications in Japan and Europe by the end of FY23.
Appier (4180) | Five Reasons to Remain Bullish
- Appier provides AI software that helps large enterprises to grow and monetize their customer base.
- Using Appier’s AI analysis tools, brands can automate the way they interact with shoppers and create new business models more efficiently
- Business is booming, it is sheltered from macro headwinds and the TAM is expanding aggressively as Appier expands into key US/EMEA markets
Lawson Confirms Seijo Ishii IPO
- Lawson Inc (2651 JP) has confirmed it will list its upscale supermarket subsidiary, Seijo Ishii early next year.
- Seijo leads in premium supermarket retailing and is growing as fast as the wealth market does, with plenty of room left to expand.
- Seijo Ishii is now building its own production and import capabilities to increase originality and could begin to challenge even some of their larger rivals.
Criteria for TOPIX Components and Prime Market Listing Criteria Should Be Discussed Separately
- The ongoing panel discussions also call for increasing TOPIX liquidity as a market need. However, TSE seems to think that it has completed the TOPIX reform for the time being.
- TSE appears to be insisting that the criteria for TOPIX stock selection be consistent with the prime market listing criteria of 10 billion Yen in tradable market capitalization.
- On the periodic replacement of TOPIX components, TSE isn’t looking at the urgent need of improving liquidity as issue to be addressed after the completion of the staged-weighting-reduction (February 2025).
Continuing Deflationary Cycle Will Not Raise Younger Generation’s Desire to Marry and Have Children
- Even couples who have decided to get married are squeezing wedding expenses, indicating that financial reasons are overshadowing the factors that keep young people from getting married.
- Real wages have continued to decline over the past 25 years, and real income per household is known to be lower in 2018 than it was in 1980.
- The deflationary cycle that has carried out by procuring cheap labor from overseas under the guise of technical intern trainees and women as non-regular workers doesn’t seem to be sustainable.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
